CD40 ligand--assessing risk instead of damage?
Freedman
Jane E
JE
D000077284:Abciximab; D000208:Acute Disease; D000787:Angina Pectoris / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D023201:CD40 Ligand / Q000097:blood*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000097:blood*; D015539:Platelet Activation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D013927:Thrombosis / Q000097:blood
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D023201:CD40 Ligand; D000077284:Abciximab